Gestala Secures $21 Million Angel Round to Advance Ultrasonic BCI Technology

Gestala, a pioneer in ultrasonic brain-computer interface (BCI) technology, is poised for expansion following a successful $21 million angel funding round. The Chengdu-based firm aims to leverage this capital to accelerate the development and deployment of its neural interface solutions. Speaking at the Bank of America Breakthrough Technology Dialogue APAC, CEO and co-founder Phoenix Peng detailed the company's strategic vision for growth. The firm's focus on ultrasonic waves represents a specialized approach to BCI, which typically seeks to establish a communication pathway between the brain's electrical activity and an external device. The $21 million injection marks a critical milestone for the startup, providing the necessary runway to transition from early-stage research toward broader operational scaling. This funding is expected to support continued research and development efforts and the expansion of their technical infrastructure within the Chinese market. While the funding is a positive signal for the emerging BCI sector, the immediate impact on global equity markets remains minimal. However, the investment highlights a sustained appetite among venture capitalists for high-risk, high-reward breakthrough medical and neural technologies within the APAC region.